These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25890869)

  • 41. Biocompatibility and setting time of CPM-MTA and white Portland cement clinker with or without calcium sulfate.
    Bramante CM; Kato MM; Assis GF; Duarte MA; Bernardineli N; Moraes IG; Garcia RB; Ordinola-Zapata R; Bramante AS
    J Appl Oral Sci; 2013; 21(1):32-6. PubMed ID: 23559109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of curing conditions on the physical properties of tricalcium silicate cement for use as a dental biomaterial.
    Formosa LM; Mallia B; Camilleri J
    Int Endod J; 2012 Apr; 45(4):326-36. PubMed ID: 22044176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arsenic release provided by MTA and Portland cement.
    Duarte MA; De Oliveira Demarchi AC; Yamashita JC; Kuga MC; De Campos Fraga S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 May; 99(5):648-50. PubMed ID: 15829892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium phosphate phase transformation produced by the interaction of the portland cement component of white mineral trioxide aggregate with a phosphate-containing fluid.
    Tay FR; Pashley DH; Rueggeberg FA; Loushine RJ; Weller RN
    J Endod; 2007 Nov; 33(11):1347-51. PubMed ID: 17963961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of composition on setting kinetics of new injectable and/or fast setting tricalcium silicate cements.
    Setbon HM; Devaux J; Iserentant A; Leloup G; Leprince JG
    Dent Mater; 2014 Dec; 30(12):1291-303. PubMed ID: 25443159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of Thermal Treatment Conditions on the Properties of Dental Silicate Cements.
    Voicu G; Popa AM; Badanoiu AI; Iordache F
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26901185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical manipulation of mineral trioxide aggregate: lessons from the construction industry and their relevance to clinical practice.
    Ha WN; Kahler B; Walsh LJ
    J Can Dent Assoc; 2015; 81():f4. PubMed ID: 26030598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydration characteristics of calcium silicate cements with alternative radiopacifiers used as root-end filling materials.
    Camilleri J
    J Endod; 2010 Mar; 36(3):502-8. PubMed ID: 20171371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The setting characteristics of MTA Plus in different environmental conditions.
    Camilleri J; Formosa L; Damidot D
    Int Endod J; 2013 Sep; 46(9):831-40. PubMed ID: 23441890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Setting time and expansion in different soaking media of experimental accelerated calcium-silicate cements and ProRoot MTA.
    Gandolfi MG; Iacono F; Agee K; Siboni F; Tay F; Pashley DH; Prati C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):e39-45. PubMed ID: 19846328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydration characteristics of zirconium oxide replaced Portland cement for use as a root-end filling material.
    Camilleri J; Cutajar A; Mallia B
    Dent Mater; 2011 Aug; 27(8):845-54. PubMed ID: 21571360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of pH and calcium ion release of a dual-cure bisphenol A ethoxylate dimethacrylate/mineral trioxide aggregate-based root-end filling material.
    Linhares Gda S; Cenci MS; Knabach CB; Oliz CM; Vieira MA; Ribeiro AS; Zanchi CH; Jacinto RC
    J Endod; 2013 Dec; 39(12):1603-6. PubMed ID: 24238456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of sodium fluorosilicate on the properties of Portland cement.
    Appelbaum KS; Stewart JT; Hartwell GR
    J Endod; 2012 Jul; 38(7):1001-3. PubMed ID: 22703670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The physical properties of accelerated Portland cement for endodontic use.
    Camilleri J
    Int Endod J; 2008 Feb; 41(2):151-7. PubMed ID: 17931386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the dimensional changes of mineral trioxide aggregate sealer.
    Camilleri J; Mallia B
    Int Endod J; 2011 May; 44(5):416-24. PubMed ID: 21255041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comments on "arsenic release provided by MTA and Portland cement" by Duarte MA, et al.
    Primus CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):416-7; author reply 417-8. PubMed ID: 16545699
    [No Abstract]   [Full Text] [Related]  

  • 57. Mineral trioxide aggregate material use in endodontic treatment: a review of the literature.
    Roberts HW; Toth JM; Berzins DW; Charlton DG
    Dent Mater; 2008 Feb; 24(2):149-64. PubMed ID: 17586038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical and physical properties of radiopaque Portland cement formulation with reduced particle size.
    Elnawawy HM; Kutty MG; Yahya NA; Kasim NHA; Cooper PR; Camilleri J; Ahmed HMA
    Dent Mater J; 2024 Sep; 43(5):672-682. PubMed ID: 39261022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physicochemical properties of calcium silicate cements associated with microparticulate and nanoparticulate radiopacifiers.
    Bosso-Martelo R; Guerreiro-Tanomaru JM; Viapiana R; Berbert FL; Duarte MA; Tanomaru-Filho M
    Clin Oral Investig; 2016 Jan; 20(1):83-90. PubMed ID: 25952552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemical composition, radiopacity, and biocompatibility of Portland cement with bismuth oxide.
    Hwang YC; Lee SH; Hwang IN; Kang IC; Kim MS; Kim SH; Son HH; Oh WM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):e96-102. PubMed ID: 19157923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.